Discontinued — last reported Q1 '20

Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryProfitability

SignalContext dependent

VolatilityStable

First reportedQ3 2017

Last reportedQ1 2020

A trend of decreasing amortization indicates that the company's current intangible assets are nearing the end of their useful lives.

This represents the projected non-cash expense associated with the amortization of finite-lived intangible assets for th...

Commonly reported by large-cap pharmaceutical firms to provide visibility into long-term earnings quality.

Metric ID: finite_lived_intangible_assets_amortization_year_5

1 periods

	Q4 '25
Value	$2.70B

What is Merck & Co.'s finite-lived intangible assets - expected amortization expense (year five)?: Merck & Co. (MRK) reported finite-lived intangible assets - expected amortization expense (year five) of $2.70B in Q4 2025.
What does finite-lived intangible assets - expected amortization expense (year five) mean?: The expected accounting expense for intangible assets in the fifth year from now.